semaj83/ctmatch_classification huggingface dataset:
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Papanicolaou Smear female, between 18 and 45 years of age and must have recently experienced an abnormal pap results within the past 3 months  has any condition which in the opinion of the investigator might interfere with the evaluation of the study objectives has other concurrent/active STD's has a history of known prior vaccination with an HPV vaccine has a history of recent (within 1 year from date of enrollment) or ongoing alcohol abuse or other drug abuse
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 25.0-55.0,  Patient With Invasive Cervical Carcinoma Patient With CIN Lesion Patient With HPV Infected Patients Without Histopathologic Lesion Normal Populations. Healthy volunteers People infected with HPV type 16 but without CIN lesions Patients with CIN lesions Patients with cervical cancer from National Taiwan University Hospital Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-24.0,  Cervical Cancer Precancerous Condition Currently enrolled in a college, university, or community college in the Greater Cleveland metropolitan area Currently single and never married Not specified Not specified
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer years and older Ability to speak and clearly understand English Female patients  No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.) Women who have had Pap smears within the previous 10 months Women under the age of 18 Women who are pregnant Inability to give informed consent in English
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 25.0-80.0,  Cervical Cancer Healthy volunteers People infected with HPV type 16 but without CIN lesions Patients with CIN lesions Patients with cervical cancer from National Taiwan University Hospital Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-26.0,  Human Papillomavirus Infection Between the age of 18 and 26 years Registered female sex worker living in Lima Healthy with no known immune deficiency Willing to participate in a study of HPV vaccine including a Pap smear, three pregnancy tests, blood draws, and three vaccine administrations over 7 months Willing to provide informed consent  Currently pregnant or planning to get pregnant in the next six months Known immune deficiency disorder Current receipt of immunosuppressive drugs Allergy to yeast or known contraindication to HPV vaccine Women who have had their cervix removed Previous HPV vaccination Current fever over 100 degrees Fahrenheit
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 9.0-26.0,  Inflammatory Bowel Disease Uterine Cervical Dysplasia Women 9-26 years of age Have inflammatory bowel disease (ie. Crohns disease or ulcerative colitis)  Pregnancy Taking corticosteroids Allergy to yeast aluminum component of the HPV vaccine Positive for all HPV types in the Gardasil vaccine—6, 11, 16, 18
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 21.0-30.0,  Cervical Neoplasia HPV Infections To be eligible to receive crossover vaccination, participants must fulfill all of the following Participation Status: Women previously randomized into the HPV-16/18 vaccine trial 04-C-N191, also known as the Costa Rica Vaccine Trial Planned Residence: Residents of Guanacaste or Puntarenas Province or willingness to visit one of the study clinics for participation Consent: Written informed consent obtained prior to enrollment into the crossover protocol  The following will be checked for all potential participants at the time of enrollment. If any apply, the participant will not be included in the study History of (a) allergic reaction (e.g., difficulty breathing) after receipt of any vaccine, (b) hypersensitivity to latex History of vaccine related adverse events during the vaccination phase that, at the discretion of the investigators, preclude vaccination during the crossover phase Are receiving vaccination with Cervarix , are sexually experienced and of childbearing potential (i.e., not surgically sterilized), and are unwilling to use an effective method of birth control for 30 days before vaccination until 60 days after the last Cervarix vaccination (approximately 9 months). Acceptable forms of birth control abstinence, surgical sterilization, hormonal contraceptives (e.g., oral, injectable, implant, and patch), intrauterine devices, and diaphragm or condom History of chronic condition that per attending doctor opinion precludes her from receiving vaccination (e.g., no proper treatment available or participant is unwilling to stay under proper treatment) The participant has a diagnosed autoimmune illness (per the specific requirement of the IRB) The vaccine or vaccines the participant is interested in receiving are contraindicated in her case
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  HPV-related Cytological Abnormalities on PAP Smear (LSIL) women with a new LSIL diagnosis an HPV positivity on PAP smear  women over 65 immunocompromised patients (because of disease or drugs)
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Intraepithelial Neoplasia Cervical Smears HPV DNA Probes Diagnosis of ASCUS or LSIL years or older Able to give informed consent with reasonable likelihood of follow-up  Previous Hysterectomy History of excisional or ablative treatment of cervix, such as laser treatment, radiation therapy, cauterization (burning), freezing or surgery such as cone biopsy or LEEP Already known to be pregnant Already known to be HIV positive (HIV may negatively affect the clinical history of HPV, making triage less appropriate
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Papillomavirus Infection Women >= 18 years of age attending a clinic for gynaecological examination Women who agree to provide a cervical sample for human papillomavirus testing Written informed consent obtained from the subject  Referral for abnormal cervical sample at the current visit Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed History of hysterectomy Known diagnosis of immunosuppression, or patient on immunosuppressives Pregnant women Having received one or more doses of HPV vaccine prior to participating in the study
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Genital Warts Human Papilloma Virus All female patients with genital warts  Patients who are pregnant, too frail or ill for gynaeoclogical examination and refusal to participate
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Infections, Papillomavirus Cervical Cancer A female aged 21 years or more, presenting with a lesion macroscopically suggestive of invasive cervical cancer Scheduled for cervical biopsy as per routine procedure at the participating institution on the day of the visit or on a later date Written or oral-witnessed informed consent obtained from the subject prior to any study procedure No prior chemo or radiotherapy for cervical cancer
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 15.0-999.0,  Infections, Papillomavirus Cervical Cancer Subjects/Subjects' parents or guardians, who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study Women >=15 years of age attending a clinic for routine cervical screening Written informed consent obtained from the subject and/or subject's parent/guardian  Referral for abnormal cervical sample at the current visit Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed No cervical sample provided History of hysterectomy Known diagnosis of immunosuppression, or patient on immunosuppressives Pregnant female >=25 years of age
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  DNA Probes E6 Protein Uterine Cervical Neoplasms HPV have not been previously diagnosed with cervical cancer have a cervix are not pregnant are physically able to undergo routine cervical cancer screening 5) are able to provide informed consent We will not women if they have had previous cervical cancer screening because we assume that even if a few women have been screened for cervical cancer, the quality of cytology screening was very poor  are not married AND report never having had sexual intercourse 2) have had a total hysterectomy have a history of cervical cancer are physically or mentally unable to undergo routine cervical cancer screening or unable to provide informed consent are pregnant or have been pregnant in the last month -Women who are currently menstruating at the time of enrollment will be deferred from participating, and will become eligible to participate 7-14 days after menstruation has ended. The menstruating women will be advised to return for the screening 7 to 14 days after their menstrual period has concluded
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Papillomavirus Infection • the subject attended a colposcopy visit, and the referral Pap sample had a valid HPV Assay result, and the sample had an HPV Assay positive result, or the sample had an HPV Assay negative result and the subject had a consensus histology result of cervical intraepithelial neoplasia (CIN) grade 2 [CIN2] or more severe (eg, CIN2, CIN grade 3 [CIN3], or cervical cancer; "CIN2+"), or the sample had an HPV Assay negative result and the subject had a consensus histology result of normal or CIN grade 1 (<CIN2) and was randomly selected for inclusion. the referral Pap sample had a valid HPV Assay result, and the sample had an HPV Assay positive result, or the sample had an HPV Assay negative result and the subject had a consensus histology result of CIN2+, or the sample had an HPV Assay negative result and the subject had a consensus histology result of <CIN2 and was randomly selected for inclusion  Samples from evaluable subjects meeting the sample will not be tested with the AHPV-GT Assay if there is insufficient volume for AHPV-GT Assay testing or the sample was deemed unsuitable for testing (eg, stored under unacceptable conditions)
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Papilloma Virus Infection the sample had an aliquot with a valid positive or negative HPV Assay System result (from testing under protocol 2007HPVASCUS30) an aliquot is available and suitable for testing, and the sample was randomly selected for inclusion  sample integrity was compromised (eg, stored under unacceptable conditions)
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 13.0-27.0,  HPV HIV For both HIV-infected and healthy subjects Subjects aged 13-27 years, females and males Written informed consent from parent or guardian if applicable (age<18 years) For HIV-infected subjects HIV-positive Asymptomatic subjects (generalized lymphadenopathy is accepted) Lymphocyte CD4+ count > or equal to 350 cells/mm3 For subjects receiving HAART Good compliance to therapy At least two suppressed viral loads HIV-RNA (<37copies/ml9 during 6 months prior to enrollment  For female subjects (both HIV-infected and healthy) Pregnancy or breastfeeding Total hysterectomy. Participants who have undergone partial hysterectomy and have a cervix are not excluded For both females and males (HIV-infected and healthy) Prior vaccination with quadrivalent HPV vaccine Gardasil before study entry History of severe allergic reaction after previous vaccination or hypersensitivity to any vaccine component Any serious chronic or progressive disease (other than HIV) according to the judgment of the investigator Acute infection requiring therapy or fever at time of enrollment Chronic autoimmune or oncologic disease receiving chemotherapy Concomitant therapies (other than HAART)
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cervical Cancer Squamous Cell Human Papilloma Virus Infection Human Papilloma Virus-Related Carcinoma Prevention Any women who come to do the Papanicolaou test at the Barretos Cancer Hospital and in the mobile units on the remote Brazilian areas
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Atypical Squamous Cells of Undetermined Significance Cervical Cancer Cervical Intraepithelial Neoplasia Grade 1 Cervical Intraepithelial Neoplasia Grade 2 Cervical Intraepithelial Neoplasia Grade 3 Health Status Unknown Human Papilloma Virus Infection Stage 0 Cervical Cancer Able to provide informed consent in English  Have had hysterectomy Currently pregnant Received treatment of cervical dysplasia with loop electrosurgical excision procedure (LEEP), cone biopsy, laser procedure or cryotherapy within THREE years Received colposcopy of cervix within TWO years Received Pap test within ONE year Immunocompromised (positive human immunodeficiency virus [HIV] test, transplant recipient, received chemotherapy for cancer, or taking immunosuppressant drugs) Decisionally impaired adults requiring a legally authorized representative
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-90.0,  Anal Intraepithelial Neoplasia MSM with HIV negative MSM with HIV positive
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Uterine Cervical Neoplasms Referred to follow up due to one or more abnormal Pap or an HPV infection Subjects who have provided informed consent Subjects who meet the minimum age set forth by the ethics committee (EC) and/or national screening guidelines  Known to be pregnant With prior complete or partial hysterectomy involving removal of cervix Subjects with an application of chemical compounds to the cervical area 24 hour prior to study entry this includes acetic acid, iodine, spermicide, douche, anti-fungal meds Subjects on who conization, Loop electrosurgical excision procedure (LEEP), laser surgery or cryosurgery has been performed
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Human Papillomavirus Infection Couple must have been in a new relationship that started no more than six months prior to study entry Both partners plan on remaining in Montreal for at least 1 year Plan on having continued sexual contact with partner Be willing to comply with study procedures  Volunteers must not have been vaccinated against HPV (both partners) Any history of cervical, penile, oral or anal cancers Being pregnant or plan on immediately becoming pregnant
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  HPV Infection Age 30 to 65 years of age the sex life of female patients , liquid-based cytology (TCT) check no intraepithelial lesions and malignant cells , HPV DNA typing test for high-risk HPV positive (including a single high-risk type positive, and more high-risk type of positive and high-and low-risk hybrid positive) kinds of high-risk types, including HPV16, 18,31,33,35,39,45,51,52,53,56,58,59,66,68  (1) cervical intraepithelial neoplasia (CIN); (2), combined with a severe fungal, trichomonas vaginitis; (3), severe primary diseases associated with cardiovascular, liver, kidney and hematopoietic system; (4), allergies or allergy to the drug known ingredients. (5), within 30 days to accept other clinical trials of drugs or are participating in clinical trials; (6), pregnant and lactating women and to be pregnant women; (7), the researchers do not consider it appropriate clinical trials
Patient description: A 32 year old female with no previous medical history presents to clinic to discuss lab results from her most recent pap smear. She reports no complaints and is in general good health. The results of her PAP were cytology negative, HPV positive.

Clinical trial eligibility criteria: eligible ages (years): 20.0-49.0,  Cervical Intraepithelial Neoplasia Fertile women between age of 20 and 49 Patients with cervical intraepithelial neoplasia 1(CIN1) HPV(Human Papilloma Virus) positive(+) White Blood Cell Count(WBC) over 4thous/ul, Hemoglobin above over 9.0g/dL Platelet over 150thous/uL and ANC(Absolute Neutrophil Count) over 1,500 10^6/L AST(Aspartate Aminotransferase) no less than 4 times higher than normal ALT(Alanine Aminotransferase) no less than 4 times higher than normal Normal for EKG(Electrocardiography) and no active disease detected trough chest X-ray Be informed of the nature of the study and will give written informed consent  Malignant tumor in any organ other than cervical intraepithelial neoplasia Active liver disease, immune disorder and severe renal failure Leukemia, collagenosis, sclerosis, autoimmune disease, clinically significant allergic disease(mild allergic symptom not required medicine excluded) Diagnosed diabetes Taking any of followings affecting immunological reaction within 7 days (Glucocorticoid, vitamins, health food and oriental medicine etc) Pregnancy and breastfeeding Registered in other clinical trials Patients whom the investigator considers inappropriate to participate in the study